January 2, 2024 09:07 AM EST

Sanofi, Regeneron and AbbVie lead pharma TV advertisers in booming 2023

Beth Snyder Bulik

Senior Editor

Even as the ad industry laments a general downturn in traditional TV media, pharma marketers are wrapping up a blockbuster year. Pharma companies plunked down …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sanofi, Regeneron and AbbVie lead pharma TV advertisers in booming 2023

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

UK’s price watchdog says Lilly’s Alzheimer’s drug is too costly for broad uptake

Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won't need confirmatory study

Amgen preps to launch Eylea biosimilar years early after Regeneron loses appeal

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Sanofi, Re­gen­eron and Ab­b­Vie lead phar­ma TV ad­ver­tis­ers in boom­ing 2023

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Sanofi, Regeneron and AbbVie lead pharma TV advertisers in booming 2023